BMXXY Financials: bioMérieux S.A. AI Analysis

Home

Stock

BMXXY

Financials

BMXXY Financial

bioMérieux S.A.

$9.9

-18.72%

$-2.28

At close: Mar 24, 16:00:00 GMT-4

$9.9

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$12.18

Open

$9.92

Day's Range

$9.9 - $10.7

52 week range

$9.51 - $14.62

Volume

420

Avg.Volume

1.3K

Dividend yield

EPS (TTM)

0.39

Market Cap

$11.6B

What is BIOMERIEUX UNSP ADR EACH REP 0.?

bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,754 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

BMXXY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	4,069	4,069	3,979	3,674	3,589	3,376
Revenue Growth (YoY)	2%	2%	8%	2%	6%	8%
Cost of Revenue	1,761	1,761	1,764	1,617	1,580	1,375
Gross Profit	2,308	2,308	2,215	2,057	2,008	2,000
Selling, General & Admin	1,111	1,111	1,097	1,020	954	815
Research & Development	507	507	491	460	446	385
Operating Expenses	1,787	1,787	1,603	1,496	1,421	1,216
Other Non Operating Income (Expenses)	-4	-8	10	0	-2	1
Pretax Income	525	525	579	437	580	774
Income Tax Expense	128	128	154	114	140	175
Net Income	397	397	432	357	452	601
Net Income Growth	-8%	-8%	21%	-21%	-25%	49%
Shares Outstanding (Diluted)	118.76	119.01	118.76	118.8	118.44	118.89
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	3.34	3.34	3.63	3.01	3.82	5.06
EPS Growth	-8%	-8%	21%	-21%	-25%	48%
Free Cash Flow	453	453	321	107	188	534
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	56.72%	56.72%	55.66%	55.98%	55.94%	59.24%
Operating Margin	12.8%	12.8%	15.35%	15.26%	16.35%	23.22%
Profit Margin	9.75%	9.75%	10.85%	9.71%	12.59%	17.8%
Free Cash Flow Margin	11.13%	11.13%	8.06%	2.91%	5.23%	15.81%
EBITDA	959	959	936	731	654	842
EBITDA Margin	23.56%	23.56%	23.52%	19.89%	18.22%	24.94%
D&A For EBITDA	438	438	325	170	67	58
EBIT	521	521	611	561	587	784
EBIT Margin	12.8%	12.8%	15.35%	15.26%	16.35%	23.22%
Effective Tax Rate	24.38%	24.38%	26.59%	26.08%	24.13%	22.6%

Follow-Up Questions

What are bioMérieux S.A.'s key financial statements?



According to the latest financial statement (Form-10K), bioMérieux S.A. has a total asset of $0, Net profit of $397

What are the key financial ratios for BMXXY?



bioMérieux S.A.'s Current ratio is 0, has a Net margin is 9.75, sales per share of $34.18.

How is bioMérieux S.A.'s revenue broken down by segment or geography?



bioMérieux S.A. largest revenue segment is Clinical Applications, at a revenue of 33,738,000,000 in the most earnings release.For geography, Americas is the primary market for bioMérieux S.A., at a revenue of 2,054,199,999.

Is bioMérieux S.A. profitable?



yes, according to the latest financial statements, bioMérieux S.A. has a net profit of $397

Does bioMérieux S.A. have any liabilities?



no, bioMérieux S.A. has liability of 0

How many outstanding shares for bioMérieux S.A.?



bioMérieux S.A. has a total outstanding shares of 0

bioMérieux S.A. (BMXXY) Financial

BMXXY Stock Price Chart